Clinical trials: At Least 1 Month From Diagnosis

Pancreatic Exocrine Insufficiency

Evaluation of Safety and Tolerability of Creon Micro in Children Younger Than Four Years With Pancreatic Exocrine Insufficiency

• Completed
• Age: Up to 4 years
• Phase 3
• Results posted

The purpose of this study is to evaluate the safety and tolerability of Creon micro in children younger than four years with pancreatic exocrine insufficiency.

Trial name

NCT01747330

Testing

Pancreatin

Where

9 sites in Russia

Volunteers

40 people

Sponsor

Abbott Products